Aggrastat

This study aims to investigate the short-term efficacy and safety of intracoronary tirofiban administration during emergency… (More)

We evaluated the acute effect of intracoronary administration of tirofiban on no-reflow phenomenon in patients with ST-segment… (More)

BACKGROUND We investigated whether an additional intracoronary tirofiban bolus administration following upstream intravenous… (More)

Objective To observe the efficacy and the safety with intracoronary use of tirofiban therapy in acute myocardium infarction… (More)

Editor—We read with interest the report of ‘bridging’ antiplatelet therapy with tirofiban during temporary withdrawal of… (More)

Objective To study the effect and safety of tirofiban hydrochlorid in patients with acute coronary syndromes (ACS) during their… (More)

Glycoprotein IIb/IIIa inhibitor therapy during primary percutaneous coronary intervention (PCI) decreases the incidence of major… (More)

Acute peripheral arterial occlusive disease is an important factor affecting the mobility and mortality rate of elderly patients… (More)

The authors investigated the effects of the platelet glycoprotein IIb/IIIa platelet inhibitor, tirofiban, on stent thrombosis in… (More)

Therapy involving the use of anti-GPIIb-IIIa inhibitors has progressively evolved in recent years for patients undergoing… (More)